Results 191 to 200 of about 11,499 (250)

Vildagliptin attenuates carrageenan-induced air pouch inflammation in rats via modulation of COX-2/ PGF-2α and NF-κB signaling cascade [PDF]

Mariam H. Fawzy, Ibtisam el kholy, Naglaa Hosny, Mansour Abdullah   +3 more
openalex   +1 more source

A prospective open labelled study of effect of vildagliptin with metformin in patients with type 2 diabetes mellitus

, 2019
S. Lavakumar, R. S. Jacob Jesurun
openalex   +2 more sources

Comparison of renal function of the patients receiving linagliptin or vildagliptin in uncontrolled type 2 diabetes mellitus: An observational study in the backdrop of the COVID-19 pandemic.

Indian J Pharmacol
Chaudhuri S, Biswas S, Mukhopadhyay S, Dasgupta S.   +3 more
europepmc   +1 more source

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

The Glycemic Outcomes of Metformin with Add-on Vildagliptin or Sitagliptin in T2DM

Abubakar Mohammed, Priya Burra Sindu, Himaja Yeddanapudi Sree, Harini Nallandhigal   +3 more
openalex   +2 more sources

Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats. [PDF]

World J Gastroenterol
Oyama M, Kaji K, Nishimura N, Hanatani J, Nakatani T, Nishimura N, Shibamoto A, Asada S, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Yoshiji H.   +12 more
europepmc   +1 more source

Identification, Isolation and Structural Elucidation of New Inner Salt Impurity in Vildagliptin and Metformin Tablet by Using Supercritical Fluid Chromatography, NMR, HRMS. [PDF]

J Sep Sci
Meganathan SK, Sahoo BK, Reddy YR, Rajani K, Reddy PR.   +4 more
europepmc   +1 more source

Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes [PDF]

core   +1 more source

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation. [PDF]

Acta Derm Venereol
Hung CT, Chung CH, Weng TH, Tsai CT, Chien WC, Chang YL.   +5 more
europepmc   +1 more source